Cover Image
市場調查報告書

AltraVax Inc.:產品平台分析

AltraVax Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 293924
出版日期 內容資訊 英文 23 Pages
訂單完成後即時交付
價格
Back to Top
AltraVax Inc.:產品平台分析 AltraVax Inc. - Product Pipeline Review - 2015
出版日期: 2015年04月15日 內容資訊: 英文 23 Pages
簡介

AltraVax Inc.是致力於研發傳染疾病及相關症狀之預防與治療用疫苗的生物製藥公司。 該公司活用免疫原最佳化系統,開發B型肝炎和登革熱的治療藥。

本報告提供AltraVax Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,以及後期階段及中止的計劃等相關資訊。

AltraVax Inc.的基本資料

  • AltraVax Inc.概要
  • 主要資訊
  • 企業資料

AltraVax Inc.:R&D概要

  • 主要的治療範圍

AltraVax Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

AltraVax Inc.:開發中產品概況

  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

AltraVax Inc.:藥物簡介

  • dengue vaccine (tetravalent)
  • equine encephalitis vaccine
  • hepatitis B vaccine
  • HIV-1 vaccine
  • influenza B vaccine
  • influenza vaccine
  • pandemic influenza H5 vaccine

AltraVax Inc.:開發平台分析

  • 標的別
  • 各分子類型

AltraVax Inc.:最近的開發平台趨勢

AltraVax Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06920CDB

Summary

Global Markets Direct's, 'AltraVax Inc. - Product Pipeline Review - 2015', provides an overview of the AltraVax Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of AltraVax Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of AltraVax Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of AltraVax Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the AltraVax Inc.'s pipeline products

Reasons to buy

  • Evaluate AltraVax Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of AltraVax Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the AltraVax Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of AltraVax Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of AltraVax Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of AltraVax Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • AltraVax Inc. Snapshot
    • AltraVax Inc. Overview
    • Key Information
    • Key Facts
  • AltraVax Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • AltraVax Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • AltraVax Inc. - Pipeline Products Glance
    • AltraVax Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • AltraVax Inc. - Drug Profiles
    • dengue (tetravalent) vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • equine encephalitis vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • hepatitis B vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HIV-1 vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • influenza vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • pandemic influenza vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • seasonal influenza B vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • AltraVax Inc. - Pipeline Analysis
    • AltraVax Inc. - Pipeline Products by Target
    • AltraVax Inc. - Pipeline Products by Molecule Type
  • AltraVax Inc. - Recent Pipeline Updates
  • AltraVax Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • AltraVax Inc., Key Information
  • AltraVax Inc., Key Facts
  • AltraVax Inc. - Pipeline by Indication, 2015
  • AltraVax Inc. - Pipeline by Stage of Development, 2015
  • AltraVax Inc. - Monotherapy Products in Pipeline, 2015
  • AltraVax Inc. - Preclinical, 2015
  • AltraVax Inc. - Discovery, 2015
  • AltraVax Inc. - Pipeline by Target, 2015
  • AltraVax Inc. - Pipeline by Molecule Type, 2015
  • AltraVax Inc. - Recent Pipeline Updates, 2015
  • AltraVax Inc., Other Locations

List of Figures

  • AltraVax Inc. - Pipeline by Top 10 Indication, 2015
  • AltraVax Inc. - Pipeline by Stage of Development, 2015
  • AltraVax Inc. - Monotherapy Products in Pipeline, 2015
  • AltraVax Inc. - Pipeline by Top 10 Target, 2015
  • AltraVax Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top